HEMATOLOGY

Cell(s) of Origin of Langerhans Cell Histiocytosis

Mar 1, 2017 by in HEMATOLOGY Comments Off on Cell(s) of Origin of Langerhans Cell Histiocytosis

Langerhans cell histiocytosis (LCH) is heterogeneous disease characterized by common histology of inflammatory lesions containing Langerin + (CD207) histiocytes. Emerging data support a model in which MAPK activation in self-renewing…

read more

Dedication

Mar 1, 2017 by in HEMATOLOGY Comments Off on Dedication

Robert J. Arceci, MD, PhD at a recent Nikolas Symposium This issue of the Hematology/Oncology Clinics of North America is dedicated to the memory of Dr Bob Arceci, who died…

read more

Thyroid Gland Malignancies

Mar 1, 2017 by in HEMATOLOGY Comments Off on Thyroid Gland Malignancies

Surgery remains the most important effective treatment for differentiated (DTC) and medullary thyroid cancer (MTC). Radioactive iodine (RAI) is another important treatment but is reserved only for DTC whose disease…

read more

Supportive Care and Survivorship Strategies in Management of Squamous Cell Carcinoma of the Head and Neck

Mar 1, 2017 by in HEMATOLOGY Comments Off on Supportive Care and Survivorship Strategies in Management of Squamous Cell Carcinoma of the Head and Neck

Supportive care and survivorship strategies in the management of head and neck squamous cell carcinoma (HNSCC) revolve around continued collaborative efforts aimed at early identification and intervention for locoregional disease…

read more

Salivary Gland Malignancies

Mar 1, 2017 by in HEMATOLOGY Comments Off on Salivary Gland Malignancies

Salivary gland malignant tumors represent a diverse group of neoplasms. Their low incidence makes research studies challenging, with most therapeutic recommendations based on case reviews, single-arm trials, or small randomized…

read more

Chemotherapy for Nasopharyngeal Carcinoma – Current Recommendation and Controversies

Mar 1, 2017 by in HEMATOLOGY Comments Off on Chemotherapy for Nasopharyngeal Carcinoma – Current Recommendation and Controversies

Radiotherapy is the primary treatment of nasopharyngeal carcinoma and combination chemotherapy can enhance treatment outcomes for locoregionally advanced disease. The Intergroup 0099 study using concurrent-adjuvant cisplatin-based chemoradiotherapy was the first…

read more
Get Clinical Tree app for offline access